Partnering for future innovation in animal health

We know the combined power of innovation and collaboration can quickly revolutionize animal health. Our collective success in addressing unmet needs in animal health hinges on connecting with partners across the scientific community, so together we can pursue science and solutions and build a healthier future for animals.

200+

Collaborations worldwide contributing to our pipeline and portfolio

€500 million

Investment in R&D for future innovations in animal health

30%

Of our Pipeline anchored in external innovation

Collaboration driving innovation

We focus on delivering breakthrough innovation—wherever it originates—to tackle the most important scientific challenges we face. That’s why we’re one of the industry’s leading investors in animal health innovation. We’re investing in both external innovation and our own R&D to power our research and collectively provide solutions for some of the biggest challenges in animal health.

This year we’re especially focused on pet therapeutics, particularly allergic diseases, pain, cardio-renal-metabolic diseases, oncology, central nervous system diseases, and oral health. We’re also interested in opportunities that prevent infectious diseases in livestock.

Synergies across animal and human health

At Boehringer Ingelheim, we’ve seen how learning from each other can accelerate innovation in both human and animal health. Our continued success in addressing unmet needs in animal health relies not only on internal collaboration but also on working with external partners in animal health and human pharma, who bring valuable new ideas and new science to our collective innovation journey. Watch our Beyond Boundaries video to find out more.

Connect with us

We’re excited to hear your ideas. Connect with our Animal Health Partnering team by email, through our online portal, or at an industry event.